1. Lack of concordance between Ki67 labeling index and 21-gene Breast Recurrence Score® test results in patients with ER+, HER2−, clinically node-negative breast cancer: a secondary analysis of TransNEOS neoadjuvant study. (March 2019) Authors: Narui, K.; Masuda, N.; Yamamoto, Y.; Fujisawa, T.; Toyama, T.; Kashiwaba, M.; Sakai, T.; Shibahara, Y.; Sasano, H.; Iwata, H. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P111 The effectiveness of low-dose olanzapine against CINV caused by anthracycline-containing regimen. (March 2015) Authors: Kashiwaba, M.; Komatsu, H.; Ishida, K.; Kawagishi, R.; Matsui, Y.; Otsuki, H.; Kawasaki, T.; Uesugi, N.; Sugai, T.; Wakabayashi, G. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prospective observational cohort study of bevacizumab combined with paclitaxel as the first- or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE). (April 2018) Authors: Kashiwaba, M.; Yamamoto, Y.; Yamashiro, H.; Kondo, N.; Nakamura, R.; Takahashi, M.; Toh, U.; Tsugawa, K.; Narui, K.; Tamaki, K.; Yoshinami, T.; Ohtani, S.; Kai, Y.; Takano, T.; Yanagita, Y.; Morita, S.; Toi, M.; Ohno, S. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗